Cancer news

Latest news, press releases and blog posts from Cancer Research UK.

Treatment

Some cancer drugs approved in Europe might not have sufficient evidence of survival benefits, says study

New research has found that many cancer drugs recently approved in Europe lacked evidence from clinical trials that they boosted survival or quality of life.

Our milestones: A radical change that improved breast cancer surgery

The results of a breast cancer trial we helped fund allowed surgeons to move away from ‘radical’ mastectomies towards kinder, less invasive surgeries.

Taking part in clinical trials – Tommy’s story

In 2012, Tommy Brennan was diagnosed with bladder cancer. Here, he shares his story and his experience of joining a Cancer Research UK-funded clinical trial.

Mesothelioma Awareness Day: How research is tackling the deadly legacy of asbestos

A greater understanding of the biology of mesothelioma has led to new clinical trials testing immunotherapies and targeted drugs against the disease.

News digest – lung cancer drug, vaping, HPV, and… CRISPR genome editing?

In this week's news a drug was approved for some lung cancer patients in England, and vaping could be a big piece of the quitting smoking puzzle.

Science Surgery: ‘Will cancer ever be cured?’

Answering this question isn't a simple case of 'yes' or 'no'. It depends on the way that the term ‘cancer’ is defined.

Breast cancer drug not recommended for use in England

The drug fulvestrant (Faslodex) has not been recommended in England to treat late stage breast cancer, in draft guidance.

Publishing national chemotherapy data has helped NHS hospitals make changes that should improve treatment

A year on from a big data report and some hospitals have changed how they discuss some aspects of treatment, including palliative care.

Our milestones: How a combination of events led to a cure for a rare cancer

We go back to the 1950s to find out how one of our scientists helped transform the outlook for women with a rare cancer called choriocarcinoma.

3 in 4 Cancer Drugs Fund treatments now available on NHS

Three quarters of the drugs previously only accessible to patients via the Cancer Drugs Fund (CDF) are now approved on the NHS.

Pages